Necroptotic cells may supply antigens and inflammatory cytokines to dendritic cells (DCs) for antigen cross-priming, which activates cytotoxic CD8+ T lymphocytes, resulting in tumor cell eradication through the release of DAMPs into the tissue milieu (Gong et al., 2019). The gene discussed is CD8A; the disease is neoplasm.